ALEC Alector, Inc.

NASDAQ
$2.09

Alector, Inc. (ALEC) is expected to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is $0.29 per share.

Alector Beat Consensus Estimates
Thursday, November 5, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Nov 5
Thursday · 4:05 PM ET
Earnings Whisper
-
vs $0.29
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $2.03

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Alector, Inc.

Alector Inc. is a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. Its product portfolio includes AL001, AL101, Al002 and AL003 which are in clinical stage. Alector Inc. is headquartered in South San Francisco, California.

Sector

Healthcare

Industry

Biotechnology

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.